Term
|
Definition
Inhibits presynaptic a2-adrenoceptors (autoR), which normally inhibits further NE release Blockade amplifies the amount of NE released
(Also has indirect effects on 5HT transmission) |
|
|
Term
Tertiary amine TCAs, SNRIs: MOA |
|
Definition
Non-selectively block NE/5HT reuptake -Clomipramine: 5HT>NE -Imipramine: NE>5HT -Venlafaxine: dose dependent = 5HT at low doses, both at high doses |
|
|
Term
Secondary amine TCAs: MOA |
|
Definition
Selectively block NE reuptake |
|
|
Term
|
Definition
Selectively block 5HT reuptake |
|
|
Term
|
Definition
Irreversibly inhibit MAO (effects last long after they're no longer present in the body, can take 10-14 days to resynthesize MAO to pre-drug levels after discontinuation) Cytoplasmic NE rises Transporter may work in reverse direction now, and dump NE from inside the cell into the synapse
(Also inhibits metabolism of 5HT and so increases cytoplasmic and thus synaptic concentrations in a similar manner) |
|
|
Term
|
Definition
|
|
Term
People with MDD need ___ with ADs to prevent relapse |
|
Definition
Long-term treatment with ADs |
|
|
Term
|
Definition
Muscarinic: dry mouth, blurred vision, constipation and urinary retention, memory impairment, sexual dysfunction H1: sedation, weight gain (chronic use) A1 (non-cardio): sexual dysfunction |
|
|
Term
|
Definition
Tachycardia (due to anticholinergic properties) Orthostatic hypotension (due to A1-blocker properties) Changes in conduction: flattened/inverted T waves, increased PR interval (normal? not really an issue; pre-existing heart disease? increased risk of AV block)
OD: severe arrhythmias |
|
|
Term
|
Definition
Ataxia or fine, rapid tremor in extremities, especially in elderly receiving high doses Initiation of manic episodes in bipolar Lower seizure threshold |
|
|
Term
|
Definition
Hepatic toxicity CNS excitation (like amphetamines): tremors, insomnia, agitation, hypomanic/manic reaction in bipolar Orthostatic hypotension due to increased stimulation of central A2-# or accumulation of false transmitter "octopamine" in PNS |
|
|
Term
|
Definition
Ingestion of indirectly-acting sympathomimetic amines Normally metabolized by MAO-A in GI tract Inhibition allows things like tyramine to enter circulation Means that there's an unusually high amount of NE released Stimulation of A1-R raises BP causing a hypertensive crisis |
|
|
Term
SSRIs, venlafaxine: S/E (4) |
|
Definition
N/V Sexual dysfunction Asthenia: apathy, concentration problems, decreased motivation, fatigue Late weight gain
No inhibition of MAO = no hypertensive crisis No anticholinergic properties = no heart conduction abnormalities or muscarinic symptoms No anti-A1 properties = no orthostatic hypotension |
|
|
Term
|
Definition
|
|
Term
|
Definition
Weight gain due to blockage of H1-R |
|
|
Term
The overall efficacy of different ADs is ___ |
|
Definition
|
|
Term
Autoreceptors are always ___ |
|
Definition
|
|
Term
The presynaptic transporter is the ___ |
|
Definition
Primary means for biogenic amine inactivation/removal from the synaptic cleft |
|
|
Term
|
Definition
No, it's sloppy medicine and marketing |
|
|
Term
|
Definition
Clomipramine (3) Imipramine (3) Desipramine (2) |
|
|
Term
SSRIs: drugs (6) "Some Patients Can Feel Fine Eventually" |
|
Definition
Sertraline Paroxetine Citalopram Fluoxetine Fluvoxamine Escitalopram
"Some Patients Can Feel Fine Eventually" |
|
|
Term
|
Definition
Bupropion Duloxetine Mirtazapine Venlafaxine |
|
|
Term
|
Definition
|
|
Term
|
Definition
Alprazolam Clomipramine Clonazepam Diazepam Lorazepam Oxazepam Triazolam |
|
|
Term
Flumazenil: MOA, indications |
|
Definition
Competitive BZ-R antagonist
Indicated for rapid reversal of BZ effects when BZs are used as an anethesia adjunct in outpatient surgery |
|
|
Term
GAD is most commonly treated using ___ b/c ___ |
|
Definition
Benzos Efficacy and favorable S/E |
|
|
Term
|
Definition
BZs SSRIs Venlafaxine Buspirone |
|
|
Term
Benzos produce a ___ of neuronal systems with more potent effects at ___ |
|
Definition
General depression Polysynaptic connections |
|
|
Term
BZs: pharmacologic effects (instant) |
|
Definition
Sedative-hypnotic Anti-anxiety Anti-convulsant Muscle relaxant (spinal cord level) Anterograde amnesia (surgery) |
|
|
Term
BZs: MOA "Barbie stays longer" |
|
Definition
Bind to GABA-R between alpha-gamma subunits Enhance chloride-channel opening More chloride flows into the cell Hyperpolarization and thus inhibition
They are not direct GABA-R agonists! |
|
|
Term
|
Definition
Sedative hypnotics that produce super amnesia
Have no anti-anxiety, anti-convulsant, or skeletal muscle relaxant effects |
|
|
Term
|
Definition
Eszopiclone Zaleplon Zolpidem |
|
|
Term
Z-drugs: pharmacologic effects (6) |
|
Definition
BZ-R agonists Short t1/2 (which make them good sedative hypnotics) Little effect on sleep stages Mild S/E: drowsiness, dizziness, headache Less abuse potential No alcohol potentiation |
|
|
Term
Ramelteon: MOA, indications |
|
Definition
Melatonin-1 and Melatonin-2-R agonist in suprachiasmatic nucleus Helps maintain circadian rhythm and normal sleep/wake cycle
Indicated for insomnia with difficulty with onset of sleep |
|
|
Term
Ramelteon: pharmacologic effects (4) |
|
Definition
No affinity for GABA-A-R Short t1/2 Mild S/E: drowsiness, dizziness, headache No abuse potential |
|
|
Term
|
Definition
Primarily metabolized in liver via oxidation In the case of ozazepam, it's conjugated to glucoronic acid, rendering it inactive, and excreted in urine (this process is unaffected by aging, unlike oxidation) |
|
|
Term
|
Definition
Sedation Dizziness Uncoordination Impaired cognitive function Paradoxical agitation
Addictive with continued usage (>8mo)
Minimal OD potential on their own, but effects are potentiated with alcohol (both are depressants)
Little organ toxicity, minimal capacity to induce hepatic enzymes |
|
|
Term
|
Definition
Usually in patients taking high doses or using BZs for >8mo, but can occur at clinically accepted doses Avoided by slowly tapering the dose
Usually a flu-like syndrome: muscle cramps, ab discomfort, diarrhea Can cause seizures (more frequent with short t1/2) |
|
|
Term
Buspirone: MOA, pharmacologic effects (4) |
|
Definition
Directly activates 5HT1A-R, which increases K conductance, thus hyperpolarizing the neuron and inhibiting firing
Slower onset of action (need a BZ to fill in while the buspirone has yet to "take") S/E: dizziness, nausea No interaction with alcohol No dependence or withdrawal |
|
|
Term
Benzos may help ___ anticipatory anxiety associated with panic attacks but may be ___ against the condition itself |
|
Definition
Minimize Relatively ineffective |
|
|
Term
Panic Disorder: BZ usage, risks of alprazolam |
|
Definition
High potency preferred b/c lower potency BZs cause too much sedation
May need higher doses of alprazolam than would be used for GAD Run the risk of seizures and severe withdrawal upon cessation |
|
|
Term
Panic Disorder: drug classes (4) |
|
Definition
|
|
Term
Panic Disorder: TCA/MAOI/SSRI usage |
|
Definition
Use the same doses for the same periods of time (as depression) to obtain effective control of PD symptoms |
|
|
Term
|
Definition
|
|
Term
OCD-effective drugs must ___ |
|
Definition
|
|
Term
OCD: Clomipramine has ___ but it's most distinctive among the TCAs for ___ |
|
Definition
NE-reuptake blocking effects Potent inhibition of 5HT reuptake |
|
|
Term
|
Definition
SSRIs for women suffering from PTSD due to sexual/physical assault
No drug has proved effective for combat vets |
|
|
Term
|
Definition
SSRIs
TCAs are ineffective! |
|
|